- Previous Close
5.1400 - Open
5.1400 - Bid 3.6800 x 100
- Ask 6.3400 x 100
- Day's Range
4.9100 - 5.1400 - 52 Week Range
4.3200 - 9.3300 - Volume
3,517,258 - Avg. Volume
4,140,098 - Market Cap (intraday)
1.175B - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1700 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.75
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
www.ardelyx.comRecent News: ARDX
View More
Performance Overview: ARDX
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ARDX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ARDX
View MoreValuation Measures
Market Cap
1.18B
Enterprise Value
1.08B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.48
Price/Book (mrq)
6.78
Enterprise Value/Revenue
3.23
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.73%
Return on Assets (ttm)
-4.76%
Return on Equity (ttm)
-23.01%
Revenue (ttm)
333.62M
Net Income Avi to Common (ttm)
-39.14M
Diluted EPS (ttm)
-0.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
250.1M
Total Debt/Equity (mrq)
103.28%
Levered Free Cash Flow (ttm)
-5.82M
Research Analysis: ARDX
View MoreResearch Reports: ARDX
View MoreDaily – Vickers Top Buyers & Sellers for 02/27/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/23/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 12/27/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 12/26/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.